You are here

Vitamin D improves muscle function

Vitamin D improves muscle function

April 8, 2013. The March, 2013 issue of The Journal of Clinical Endocrinology & Metabolism reports the finding of researchers at Newcastle University in England of a positive effect for vitamin D supplementation on the muscle function of deficient adults.

Twelve participants underwent magnetic resonance spectroscopy of a lower leg muscle before and after twelve weeks of vitamin D supplementation in order to evaluate phosphocreatine recovery kinetics as an assessment of mitochondrial oxidative phosphorylation. Phosphocreatine is used by the cells’ mitochondria to manufacture adenosine triphosphate (ATP)--a molecule needed by muscle for movement. Rapid replenishment of phosphocreatine by the mitochondria following muscle contraction is an indicator of improved mitochondrial efficiency.

Researchers Akash Sinha and colleagues observed a reduction in phosphocreatine recovery half-time after treatment with vitamin D, which indicates an improvement in maximal oxidative phosphorylation. "The scans provided a unique window into what is really going on in the muscle as it works,” Dr Sinha explained. “Examining this small group of patients with vitamin D deficiency who experienced symptoms of muscle fatigue, we found that those with very low vitamin D levels improved their muscle efficiency significantly when their vitamin D levels were improved."

"We have proved for the first time a link between vitamin D and mitochondria function,” Dr Sinha announced. "Of the patients I see, around 60% are vitamin D deficient and most people living north of Manchester will struggle to process enough vitamin D from sunlight alone, particularly during winter and spring. So a simple vitamin D tablet could help boost your energy levels – from within the cells."

http://jcem.endojournals.org/content/98/3/961.full

From a BBC article:

"Pilot studies and regional monitoring suggests that vitamin D deficiency is likely to affect at least half the UK's white population, up to 90% of the multi-ethnic population and a quarter of all children living in Britain."

Particularly coming out of a long and sunless few months, a couple of medics I know have said that they reckon pretty much everyone is vitamin D deficient at the moment. I know I was, so took supplements (recommended by my CML consultant).

You can get a year's supply direct from Amazon for under a tenner.

Hannah, you are obviously worried but please try not to. 2n gen TKIs are equally effective in targeting the BCR-ABL gene. The difference is only in the side effect profile of each and in the different administration regimes. i.e nilotinib needs fasting twice daily etc. Dasatinib is a very effective drug for some people as many on this forum would tell you. Imatinib was the first drug of this kind and whilst it is extremely good and has saved many lives, the later drugs were developed to improve on its effects. Which they seem to have done according to research/clinical trial data and real world patient experience.
A lot of people still respond very well to imatinib and there is no reason for them to change therapy.

The article you cite is not saying that the drug is better or worse than the others- it is just reporting on how dasatinib produces mechanisms in the immune response that 'might' cause its more severe rarer side effects in a small group of people- ie. pleural effusion (fluid build up on the lungs) or thrombocytopaenia (low levels of platelets).

'Thus, dasatinib induces a unique, rapid mobilization and activation of cytotoxic, extravasation-competent lymphocytes, which may not only enhance antileukemia immune responses but can also be causally related to the side-effect profile of the drug (pleural effusions, thrombocytopenia).'

Please try not to worry, I am sure you are carefully monitored by your clinician.

best.. Sandy